Venus Concept Announces Australian Regulatory Approval for Venus Versa™ Pro
TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has Therapeutic Goods Administration (TGA) clearance in Australia to market the Venus Versa™ Pro system. The Venus Versa Pro combines the applicator of the Venus Viva MD with the Venus Versa system which are both approved in Australia and registered in Australian Register of Therapeutic Goods (ARTG).
The Venus Versa™ Pro offers a total skin rejuvenation experience by offering three powerful technologies: Intense Pulsed Light (IPL) with SmartPulse™, NanoFractional Radio Frequency with SmartScan™, and Venus' proprietary (MP)2 technology. These technologies synergize to enable customers to benefit from a wide variety of treatments to enhance skin tone, improve tightness and smooth texture.
“We look forward to bringing our Venus Versa Pro system to Australia, a major market to which we continue to commit investment with a growing direct office presence,” said Dr. Hemanth Varghese, President and Chief Operating Officer of Venus Concept. “Venus Versa Pro continues to receive positive feedback from customers regarding its multi-modal system capabilities and we look to bring the device to more customers globally once approved with the relevant local authorities.”
